First-Line Treatments for Migraine Prevention
Beta blockers (propranolol 80-240 mg/day or timolol 20-30 mg/day), topiramate (100 mg/day), and candesartan are the recommended first-line medications for migraine prevention. 1, 2
Indications for Preventive Therapy
- Preventive therapy should be considered for patients who experience two or more migraine attacks per month with disability lasting 3 or more days per month 1, 2
- Patients who have contraindications to or failure of acute treatments should be evaluated for preventive therapy 1, 2
- Those using abortive medication more than twice per week should be considered for preventive treatment to avoid medication overuse headache 1, 2
- Patients with uncommon migraine conditions (hemiplegic migraine, migraine with prolonged aura, or migrainous infarction) are candidates for preventive therapy 1
First-Line Preventive Medications
Beta Blockers
- Propranolol (80-240 mg/day) and timolol (20-30 mg/day) have strong evidence for efficacy 1, 3
- Common side effects include dizziness, nausea, fatigue, depression, and insomnia, though these are generally well-tolerated 1
- Propranolol has demonstrated efficacy in reducing migraine frequency in controlled trials 3
Topiramate
- Recommended dose is 100 mg/day (typically 50 mg twice daily) 1, 4, 5
- Clinical trials show topiramate reduces migraine days by approximately two per month 6
- Most common side effects include paresthesia (51% at 100 mg/day), fatigue, decreased appetite, and cognitive difficulties 4, 5
- Particularly beneficial for patients concerned about weight gain, as it is often associated with weight loss 5
- Efficacy has been demonstrated even in chronic migraine with medication overuse 7
Candesartan
- Emerging evidence supports candesartan as a first-line agent 1
- Particularly useful for patients with comorbid hypertension 1
Second-Line Preventive Medications
Amitriptyline (30-150 mg/day) is recommended as a second-line agent 1
May be particularly effective in patients with mixed migraine and tension-type headache 1
Common side effects include weight gain, drowsiness, and anticholinergic symptoms 1
Flunarizine (not available in the US) is a second-line option where available 1
Sodium valproate (800-1500 mg/day) or divalproex sodium (500-1500 mg/day) are second-line options 1
Third-Line Preventive Medications
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) are recommended as third-line agents 1
- In Europe, these are restricted to patients in whom other preventive medications have failed 1
- OnabotulinumtoxinA (Botox) is FDA-approved for chronic migraine prevention in adults with 15 or more headache days per month 8
Implementation of Preventive Therapy
- Start with a low dose and titrate slowly until clinical benefits are achieved or side effects limit further increases 1, 2
- Allow an adequate trial period of 2-3 months before determining efficacy 1, 2
- Monitor for medication overuse, which can interfere with preventive treatment 2
- Use headache diaries to track attack frequency, severity, duration, disability, treatment response, and adverse effects 2
Common Pitfalls to Avoid
- Failing to recognize medication overuse headache from frequent use of acute medications 2
- Inadequate duration of preventive trial (less than 2-3 months) 2
- Starting with too high a dose, leading to poor tolerability and discontinuation 1
- Not addressing comorbidities that may influence treatment selection (e.g., avoiding valproate in women of childbearing potential) 1